Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Critical RiskFDA Drug
Medications & Supplements/Dietary Supplements

MegMan Performance Booster Recalled for Undeclared Tadalafil

Agency Publication Date: February 8, 2022
Share:
Sign in to monitor this recall

Summary

Junp Hydration LLC is recalling approximately 750 cartons of MegMan Performance Booster (800 mg capsules). The product was found to contain tadalafil, an undeclared ingredient found in FDA-approved prescription medications used to treat male sexual enhancement. Because this ingredient is not listed on the label, the product is considered an unapproved drug. No incidents or injuries have been reported to date.

Risk

Undeclared tadalafil may interact with nitrates found in some prescription drugs, such as nitroglycerin, and may lower blood pressure to dangerous levels. Consumers with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates and are at higher risk of a life-threatening interaction.

What You Should Do

  1. The recalled product is MegMan Performance Booster (800 mg capsules) sold in 10-count blister packs within a carton (UPC 8 48998 00091 2, ASIN B08Z74KS88). This recall specifically affects lot number 2010291 with an expiration date of 01/07/2024.
  2. If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact Junp Hydration LLC for further instructions.
  3. Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls for more information.

Your Remedy Options

You have 2 options:

๐Ÿ’ฐOption 1: Full Refund
How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund
๐Ÿ—‘๏ธOption 2: Dispose of Product
How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: MegMan Performance Booster (800 mg)
Variants: 10-count blisters, 800 mg capsules
UPC Codes:
848998000912
Lot Numbers:
2010291 (Exp 01/07/2024)

ASIN B08Z74KS88; Recall #: D-0557-2022

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 89543
Status: Resolved
Manufacturer: Junp Hydration LLC
Sold By: Amazon Marketplace
Manufactured In: United States
Units Affected: 750 cartons
Distributed To: Nationwide
Agency Last Updated: February 11, 2022

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.